Rénibus Therapeutics is a biotech company dedicated to transforming the cardio-renal disease treatment paradigm by focusing on the prevention, treatment, and diagnostic testing of kidney disease.

Pharmaceutical

Rénibus Therapeutics

Rénibus Therapeutics' headquarters in Southlake, TX, United States

Jamie A. Donadio

Mark Nuttall

Richard Lawson

Bhupinder Singh

Norma Schafer

Maureen Early

Sheena Perez

Fiona Stavros

D. Jeff Keyser

Jack Reed

Stewart Turner

Bob Schnitzius

George Pickard

Nels Bergmark

Ravi Thadhani,

Jean-Claude Tardif

Henrik Rasmussen

Alexander Zarbock

Rakesh Arora

Carlos Guillem

Kevin W. Lobdell

Patrick T. Murray

Andrew Shaw

Alpesh Amin

Glenn M. Chertow

Javed Butler

Andre Lamy

Hamid Rabb

The Scientific Research Team at Rénibus Therapeutics is dedicated to advancing innovative therapies for cardio-renal diseases. Comprising experts in various fields, the team focuses on conducting rigorous scientific studies, translating research findings into clinical applications, and developing diagnostic tests to improve kidney disease outcomes. Their collaborative efforts aim to drive pre-clinical and clinical advancements, ultimately transforming patient care in this critical area.

Scientific Research Team

The Clinical Development and Quality Assurance team at Rénibus Therapeutics is responsible for designing and overseeing clinical trials that evaluate the safety and efficacy of innovative therapies for cardio-renal diseases. They ensure compliance with regulatory standards, uphold quality assurance protocols, and collaborate closely with medical and regulatory affairs to facilitate the successful advancement of clinical programs from conception to approval.

Clinical Development and Quality Assurance

The Finance and Operations team at Rénibus Therapeutics is responsible for overseeing the company’s financial planning, budgeting, and human resources functions, ensuring optimal resource allocation to support innovative research and development. This team also manages operational efficiencies, facilitating seamless coordination between departments to drive strategic initiatives focused on transforming the treatment of cardio-renal diseases.

Finance and Operations

The Leadership Team at Rénibus Therapeutics is responsible for crafting and executing the company’s strategic vision, ensuring the alignment of operational and financial goals with its mission to innovate in cardio-renal disease treatment. Composed of key executives, including the Chief Medical Officer and the Chief Financial Officer, the team oversees clinical development, operational efficiency, and financial stewardship, all while fostering collaboration across departments to drive advancements in kidney disease prevention and care.

Leadership Team

Rénibus Therapeutics

Org chart

Board & advisors

Teams

Scientific Research Team

Clinical Development and Quality Assurance

Finance and Operations

Leadership Team

Offices

Rénibus Therapeutics

Org chart

Board & advisors

Teams

Scientific Research Team

Clinical Development and Quality Assurance

Finance and Operations

Leadership Team

Offices

Related companies